Back to Results
First PageMeta Content
Microbiology / Vaccination / Herpes / Viral diseases / Herpes simplex / Aciclovir / Virology / Herpesviridae / DNA vaccination / Medicine / Sexually transmitted diseases and infections / Biology


JOURNAL OF VIROLOGY, Jan. 2005, p. 410–[removed]538X/05/$08.00⫹0 doi:[removed]JVI[removed]–[removed]Vol. 79, No. 1 Comparative Efficacy and Immunogenicity of Replication-Defective,
Add to Reading List

Document Date: 2005-01-25 13:30:36

Open Document

File Size: 220,06 KB

Share Result on Facebook

City

Southbridge / Carlsbad / Emeryville / Minneapolis / Dalai / Boston / Kalamazoo / L. A. / Indianapolis / Bethesda / Foster City / Chantilly / San Diego / Rockford / Chicago / HOSHINO ET / St. Louis / /

Company

Fleming / Chiron Corp. / Avant Immunotherapeutics Inc. / R. E. Sekulovich A. E. / Bernstein / Becton Dickinson / Charles River Laboratories / Needham / Abbott Labs / Pharmacia / /

Country

Guinea / United States / /

Currency

BRL / pence / USD / /

/

Event

Product Issues / FDA Phase / /

Facility

National Institute of Allergy / Center Dr. / J. P. Weir / Laboratory of Clinical Infectious Diseases / laboratory of D. M. Knipe / /

/

IndustryTerm

prevention of primary and recurring genital disease / early gene products / /

MedicalCondition

sexually transmitted disease / recurrent genital herpes / acute and recurrent disease / ocular infection / infectious process / genital herpes / genital herpes infections / strain / primary and recurrent disease / natural infection / human infection / Herpes / asymptomatic infections / primary infection / significantly milder acute disease / influence human immunodeficiency virus infection / each ganglion / recurrent genital disease / established infections / recurrent HSV disease / acute and recurrent genital disease / acute disease / less local inflammation / primary genital infection / Infections / genital disease / vaginal infection / localized infection / established recurrent genital herpes / lytic infections / recurrent infection / disease / cutaneous herpes simplex virus infection / comparably severe acute infections / genital infection / erythema / both acute disease / latent infection / experimental recurrent genital herpes / infection / productive and latent infection / subsequent disease / ganglion DNA / severe and disseminated disease / herpes simplex virus / milder acute disease / herpesvirus infections / /

MedicalTreatment

Immunization / antibiotics / vaccination / immunotherapy / /

Organization

Harvard Medical School / National Institute of Health / Laboratory of Clinical Infectious Diseases / Department of Microbiology / National Institute of Allergy and Infectious Diseases / International Congress / FDA / Department of Microbiology and Molecular Genetics / /

Person

J. M. Douglas / Jr. / Kimberly Beacht / Anna McEvoy / Philip Krause / Sharon Evans / Mir Ali / Francisco Leon / Brian Kelsall / David Beattie / /

/

Position

Corresponding author / Governor / /

Product

penicillin / acyclovir / medroxyprogesterone acetate / Sigma / gentamicin / amphotericin B / Depo-Provera / CD8 / mutant viruses / vaccines / replication cycle / mutant / mutant dl5 / strain / /

ProvinceOrState

New Jersey / Minnesota / Virginia / Alabama / Maryland / Illinois / Indiana / Michigan / Missouri / S. K. / California / Massachusetts / /

PublishedMedium

JOURNAL OF VIROLOGY / Clinical Infectious Diseases / /

Technology

antibodies / recombination / /

SocialTag